166 related articles for article (PubMed ID: 15546501)
1. The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression.
Akiyama S; Furukawa T; Sumizawa T; Takebayashi Y; Nakajima Y; Shimaoka S; Haraguchi M
Cancer Sci; 2004 Nov; 95(11):851-7. PubMed ID: 15546501
[TBL] [Abstract][Full Text] [Related]
2. Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose.
Uchimiya H; Furukawa T; Okamoto M; Nakajima Y; Matsushita S; Ikeda R; Gotanda T; Haraguchi M; Sumizawa T; Ono M; Kuwano M; Kanzaki T; Akiyama S
Cancer Res; 2002 May; 62(10):2834-9. PubMed ID: 12019161
[TBL] [Abstract][Full Text] [Related]
3. 2-Deoxy-D-ribose, a downstream mediator of thymidine phosphorylase, regulates tumor angiogenesis and progression.
Nakajima Y; Madhyastha R; Maruyama M
Anticancer Agents Med Chem; 2009 Feb; 9(2):239-45. PubMed ID: 19199868
[TBL] [Abstract][Full Text] [Related]
4. Prevention of hypoxia-induced apoptosis by the angiogenic factor thymidine phosphorylase.
Kitazono M; Takebayashi Y; Ishitsuka K; Takao S; Tani A; Furukawa T; Miyadera K; Yamada Y; Aikou T; Akiyama S
Biochem Biophys Res Commun; 1998 Dec; 253(3):797-803. PubMed ID: 9918807
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of metastasis of tumor cells overexpressing thymidine phosphorylase by 2-deoxy-L-ribose.
Nakajima Y; Gotanda T; Uchimiya H; Furukawa T; Haraguchi M; Ikeda R; Sumizawa T; Yoshida H; Akiyama S
Cancer Res; 2004 Mar; 64(5):1794-801. PubMed ID: 14996742
[TBL] [Abstract][Full Text] [Related]
6. 2-Deoxy-L-ribose inhibits the invasion of thymidine phosphorylase-overexpressing tumors by suppressing matrix metalloproteinase-9.
Nakajima Y; Haraguchi M; Furukawa T; Yamamoto M; Nakanishi H; Tatematsu M; Akiyama S
Int J Cancer; 2006 Oct; 119(7):1710-6. PubMed ID: 16646076
[TBL] [Abstract][Full Text] [Related]
7. [Thymidine phosphorylase and angiogenesis].
Akiyama S
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1208-11. PubMed ID: 10945018
[TBL] [Abstract][Full Text] [Related]
8. Thymidine phosphorylase suppresses Fas-induced apoptotic signal transduction independent of its enzymatic activity.
Mori S; Takao S; Ikeda R; Noma H; Mataki Y; Wang X; Akiyama S; Aikou T
Biochem Biophys Res Commun; 2002 Jul; 295(2):300-5. PubMed ID: 12150947
[TBL] [Abstract][Full Text] [Related]
9. [Influence of the thymidine phosphorylase (platelet-derived endothelial cell growth factor) on tumor angiogenesis. Catalytic activity of enzyme inhibitors].
Miszczak-Zaborska E; Smolarek M; Bartkowiak J
Postepy Biochem; 2010; 56(1):61-6. PubMed ID: 20499682
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis for the inhibition of hypoxia-induced apoptosis by 2-deoxy-D-ribose.
Ikeda R; Furukawa T; Kitazono M; Ishitsuka K; Okumura H; Tani A; Sumizawa T; Haraguchi M; Komatsu M; Uchimiya H; Ren XQ; Motoya T; Yamada K; Akiyama S
Biochem Biophys Res Commun; 2002 Mar; 291(4):806-12. PubMed ID: 11866437
[TBL] [Abstract][Full Text] [Related]
11. Thymidine phosphorylase induces angiogenesis in vivo and in vitro: an evaluation of possible mechanisms.
Sengupta S; Sellers LA; Matheson HB; Fan TP
Br J Pharmacol; 2003 May; 139(2):219-31. PubMed ID: 12770927
[TBL] [Abstract][Full Text] [Related]
12. The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors.
Matsushita S; Nitanda T; Furukawa T; Sumizawa T; Tani A; Nishimoto K; Akiba S; Miyadera K; Fukushima M; Yamada Y; Yoshida H; Kanzaki T; Akiyama S
Cancer Res; 1999 Apr; 59(8):1911-6. PubMed ID: 10213500
[TBL] [Abstract][Full Text] [Related]
13. Angiogenic factor thymidine phosphorylase increases cancer cell invasion activity in patients with gastric adenocarcinoma.
Yu EJ; Lee Y; Rha SY; Kim TS; Chung HC; Oh BK; Yang WI; Noh SH; Jeung HC
Mol Cancer Res; 2008 Oct; 6(10):1554-66. PubMed ID: 18922971
[TBL] [Abstract][Full Text] [Related]
14. Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis.
Brown NS; Bicknell R
Biochem J; 1998 Aug; 334 ( Pt 1)(Pt 1):1-8. PubMed ID: 9693094
[TBL] [Abstract][Full Text] [Related]
15. Thymidine phosphorylase: a two-face Janus in anticancer chemotherapy.
Focher F; Spadari S
Curr Cancer Drug Targets; 2001 Aug; 1(2):141-53. PubMed ID: 12188887
[TBL] [Abstract][Full Text] [Related]
16. Effects of platelet-derived endothelial cell growth factor/thymidine phosphorylase, substrate, and products in a three-dimensional model of angiogenesis.
Stevenson DP; Milligan SR; Collins WP
Am J Pathol; 1998 Jun; 152(6):1641-6. PubMed ID: 9626068
[TBL] [Abstract][Full Text] [Related]
17. [Thymidine phosphorylase inhibits apoptosis induced by anticancer agents].
Ikeda R; Furukawa T; Sumizawa T; Haraguchi M; Oiso S; Inoue I; Yamada K; Akiyama S
Nihon Yakurigaku Zasshi; 2003 Nov; 122 Suppl():84P-86P. PubMed ID: 14727531
[TBL] [Abstract][Full Text] [Related]
18. [Molecular basis for the inhibition of anticancer agents-induced apoptosis by thymidine phosphorylase].
Ikeda R
Yakugaku Zasshi; 2007 Jul; 127(7):1097-102. PubMed ID: 17603269
[TBL] [Abstract][Full Text] [Related]
19. Thymidine phoshorylase as a target for antiangiogenesis treatment.
Peters GJ; Bijnsdorp IV; Fukushima M
Nucleic Acids Symp Ser (Oxf); 2008; (52):629. PubMed ID: 18776537
[TBL] [Abstract][Full Text] [Related]
20. Thymidine phosphorylase-mediated angiogenesis regulated by thymidine phosphorylase inhibitor in human ovarian cancer cells in vivo.
Tsukagoshi S; Saga Y; Suzuki N; Fujioka A; Nakagawa F; Fukushima M; Suzuki M
Int J Oncol; 2003 May; 22(5):961-7. PubMed ID: 12684660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
